(Q43852459)

27 November 2017

title

Low dose sulprostone for termination of second and third trimester pregnancies (English)

1 reference

27 November 2017

de Boer MA

1

1 reference

27 November 2017

van Gemund N

series ordinal

2

1 reference

27 November 2017

Scherjon SA

series ordinal

3

1 reference

27 November 2017

Kanhai HH

series ordinal

4

1 reference

27 November 2017

language of work or name

1 reference

1 December 2001

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

27 November 2017

published in

1 reference

27 November 2017

volume

99

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

244-248

1 reference

Induction of labour after fetal death: a randomized controlled trial of two prostaglandin regimens

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Low-dose sulprostone for pregnancy termination in cases of fetal abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Prolonged induction to delivery time in termination of pregnancy using 16, 16-dimethyl-PGE1-methyl ester (gemeprost) for fetuses with a neural tube defect or hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Therapeutic abortion during the 2nd and 3rd trimesters of pregnancy using a synthetic derivative of prostaglandin E2, sulprostone, administrated intravenously. Based upon 182 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Induction of labour with sulprostone after foetal death and in hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Effect of causing fetal cardiac asystole on second-trimester abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900406-7

7 January 2021

10.1016/S0301-2115(01)00406-7

Identifiers

DOI

1 reference

27 November 2017

1 reference